Stock Ticker

  • Loading stock data...

Abbvie Inc (NYSE:ABBV) And Alpine Immune Sciences Inc. (NASDAQ:ALPN) Enter Partnership To Develop ALPN-101

Abbvie Inc (NYSE:ABBV) and Alpine Immune Sciences Inc. (NASDAQ:ALPN) have announced an exclusive global license and option agreement for Alpine’s best in class dual ICOS/CD28 costimulation antagonist, ALPN-101. AbbVie to co-develop ALPN-101 with Alpine ICOS and CD28 are important costimulatory molecules playing critical roles in inflammatory autoimmune diseases. Alpine’s ALPN-101 is a potent ICOS and […]

Sign Up To Get Our Latest Stocks Alerts